|
Market Cap | 157.59M | EPS (ttm) | 2.93 |
P/E | 10.16 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 4.49% |
P/S | 1.58 | EPS next 5Y | - |
P/B | 1.01 | EPS Q/Q | 27.98% |
Dividend | 2.54% | Sales Q/Q | 26.63% |
Insider Own | 18.77% | Inst Own | 38.98% |
Insider Trans | -0.80% | Inst Trans | 1.12% |
Short Float | 0.16% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 7.23K | 52W Range | 16.26 - 31.59 |
|
|
|
Peoples Bancorp of North Carolina, Inc. is a holding company, which engages in the business of owning the Bank, Peoples Bank and PEBK Capital Trust II. It operates through the following segments: Banking Operations, Community Bank Real Estate Solutions, LLC (CBRES), and Other. The Banking Operations segment focuses on the consolidated bank. The CBRES segment provides appraisal management services to community banks. The company was founded in 1999 and is headquartered in Newton, NC. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ABERNETHY JAMES S | Director | May 20 '24 | Sale | 29.90 | 1,000 | 29,900 | 82,206 | May 20 05:00 PM | ABERNETHY JAMES S | Director | Feb 23 '24 | Sale | 24.50 | 3,000 | 73,500 | 83,706 | Feb 23 05:02 PM | ABERNETHY JAMES S | Director | Dec 04 '23 | Sale | 27.12 | 2,000 | 54,240 | 43,290 | Dec 06 02:42 PM | ABERNETHY JAMES S | Director | Dec 04 '23 | Sale | 27.12 | 2,000 | 54,240 | 86,706 | Dec 06 02:42 PM | ABERNETHY JAMES S | Director | Aug 02 '23 | Sale | 21.60 | 4,000 | 86,400 | 45,290 | Aug 04 05:11 PM |
|
|
|
|
Market Cap | 43.11B | EPS (ttm) | 10.32 |
P/E | 50.58 | EPS this Y | 10.00% |
Forward P/E | 41.41 | EPS next Y | 13.91% |
PEG | 4.21 | EPS past 5Y | 18.76% |
P/S | 11.57 | EPS next 5Y | 12.00% |
P/B | 27.57 | EPS Q/Q | 10.06% |
Dividend | - | Sales Q/Q | 7.10% |
Insider Own | 1.08% | Inst Own | 90.22% |
Insider Trans | -7.47% | Inst Trans | -0.23% |
Short Float | 2.07% | Earnings | May 01/b |
Analyst Recom | 2.15 | Target Price | 579.96 |
Avg Volume | 444.81K | 52W Range | 372.50 - 583.39 |
|
|
|
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Claflin Bruce L. | Director | May 17 '24 | Sale | 540.80 | 200 | 108,160 | 161 | May 20 05:00 PM | Britt Irene Chang | Director | May 06 '24 | Option Exercise | 0.00 | 208 | 0 | 208 | May 08 07:00 PM | AYERS JONATHAN W | Director | May 06 '24 | Option Exercise | 0.00 | 257 | 0 | 265,651 | May 08 07:00 PM | ESSIG STUART | Director | May 06 '24 | Option Exercise | 0.00 | 257 | 0 | 1,974 | May 08 07:01 PM | COLLINS Asha | Director | May 06 '24 | Option Exercise | 0.00 | 257 | 0 | 779 | May 08 07:01 PM |
|
|
|
|
Market Cap | 8.92B | EPS (ttm) | 14.33 |
P/E | 11.98 | EPS this Y | 4.66% |
Forward P/E | 10.06 | EPS next Y | 5.27% |
PEG | 1.93 | EPS past 5Y | 24.61% |
P/S | 0.78 | EPS next 5Y | 6.20% |
P/B | 1.81 | EPS Q/Q | 111.35% |
Dividend | 1.69% | Sales Q/Q | 8.98% |
Insider Own | 0.81% | Inst Own | 95.44% |
Insider Trans | -2.64% | Inst Trans | -6.49% |
Short Float | 1.70% | Earnings | May 07/a |
Analyst Recom | 1.62 | Target Price | 208.80 |
Avg Volume | 334.79K | 52W Range | 118.45 - 189.48 |
|
|
|
Assurant, Inc. engages in the provision of lifestyle and housing solutions for consumer purchases. It operates through the following segments: Global Lifestyle, Global Housing, and Corporate and Other. The Global Lifestyle segment offers mobile device solutions and extended service products and related services for mobile devices, consumer electronics and appliances, vehicle protection, and related services. The Global Housing segment includes lender-placed homeowners' insurance, lender-placed manufactured housing insurance, lender-placed flood insurance, renters' insurance, and related products, voluntary manufactured housing insurance, voluntary homeowners' insurance and other specialty products. The Corporate and Other segment refers to the corporate employee-related expenses and activities of the holding company. The company was founded in 1892 and is headquartered in Atlanta, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Luthi Francesca | EVP, Chief Operating Officer | May 16 '24 | Sale | 176.36 | 6,700 | 1,181,629 | 10,748 | May 20 05:00 PM | Lonergan Robert | Chief Marketing & Risk Officer | May 16 '24 | Sale | 176.12 | 2,700 | 475,529 | 19,786 | May 20 05:00 PM | Rosenblum Jay | EVP and CLO | Nov 20 '23 | Sale | 162.16 | 2,000 | 324,326 | 7,567 | Nov 21 05:00 PM | DiRienzo Dimitry | SVP, CAO, Controller | Nov 17 '23 | Sale | 160.72 | 850 | 136,616 | 4,654 | Nov 20 05:00 PM | DZIADZIO RICHARD S | EVP and CFO | Aug 14 '23 | Sale | 143.19 | 4,000 | 572,778 | 51,893 | Aug 15 05:00 PM |
|
|
| |
|
Market Cap | 16.87B | EPS (ttm) | 6.73 |
P/E | 11.32 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | 0.81 | EPS past 5Y | 25.93% |
P/S | 1.04 | EPS next 5Y | 14.03% |
P/B | 1.05 | EPS Q/Q | 27.79% |
Dividend | 0.33% | Sales Q/Q | 11.84% |
Insider Own | 17.32% | Inst Own | 59.50% |
Insider Trans | -2.00% | Inst Trans | -3.46% |
Short Float | 0.99% | Earnings | May 06/b |
Analyst Recom | 3.00 | Target Price | 52.00 |
Avg Volume | 708.09K | 52W Range | 55.94 - 78.55 |
|
|
|
Loews Corp. is a holding company, which engages in the business of commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, and operation of a chain of hotels. It operates through the following segments: CNA Financial, Boardwalk Pipelines, Loews Hotels and Co, and Corporate. The CNA Financial segment is involved in the sale of property and casualty insurance products and services, including surety, primarily through a network of independent agents, brokers, and managing general underwriters. The Boardwalk Pipelines segment focuses on midstream portion of the natural gas and NGLs industry, providing transportation, and storage for those commodities. The Loews Hotels and Co segment refers to a chain of hotels, which are in the United States and one of which is in Canada. The Corporate segment consists of investment income from the parent company's cash and investments, parent company interest expense, and other unallocated parent company expenses. The company was founded by Laurence A. Tisch and Preston Robert Tisch on November 12, 1969 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
TISCH JONATHAN M | Co-Ch. of Bd/Off. of the Pres. | May 17 '24 | Sale | 77.60 | 50,000 | 3,880,000 | 407,799 | May 20 04:57 PM | TISCH JONATHAN M | Co-Ch. of Bd/Off. of the Pres. | May 16 '24 | Sale | 77.14 | 50,000 | 3,857,000 | 457,799 | May 16 05:03 PM | TISCH JONATHAN M | Co-Ch. of Bd/Off. of the Pres. | May 14 '24 | Sale | 77.24 | 50,000 | 3,862,000 | 507,799 | May 16 05:03 PM | TISCH ANDREW H | Director | May 09 '24 | Option Exercise | 0.00 | 1,706 | 0 | 1,726,479 | May 09 08:32 AM | BERMAN ANN E | Director | May 09 '24 | Option Exercise | 0.00 | 1,706 | 0 | 4,998 | May 09 08:34 AM |
|
|
|
|
Market Cap | 38.46M | EPS (ttm) | -19.52 |
P/E | - | EPS this Y | 44.39% |
Forward P/E | - | EPS next Y | 31.92% |
PEG | - | EPS past 5Y | 22.28% |
P/S | 0.45 | EPS next 5Y | 25.50% |
P/B | 1.68 | EPS Q/Q | 67.40% |
Dividend | - | Sales Q/Q | 4.84% |
Insider Own | 27.05% | Inst Own | 15.96% |
Insider Trans | 0.97% | Inst Trans | -12.79% |
Short Float | 12.50% | Earnings | May 15/a |
Analyst Recom | 1.00 | Target Price | 13.00 |
Avg Volume | 247.94K | 52W Range | 1.24 - 10.65 |
|
|
|
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Klein Dov | Director | May 20 '24 | Sale | 1.89 | 10,000 | 18,900 | 53,400 | May 20 04:56 PM | ROSENWALD LINDSAY A MD | President, CEO & Chairman | May 16 '24 | Buy | 1.76 | 10,000 | 17,589 | 2,873,905 | May 20 05:00 PM | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Jan 05 '24 | Buy | 2.38 | 50,000 | 118,770 | 2,863,905 | Jan 09 08:15 AM | ROSENWALD LINDSAY A MD | President, CEO & Chairman | Nov 14 '23 | Buy | 1.70 | 1,567,515 | 2,664,776 | 2,597,440 | Nov 16 05:50 PM | WEISS MICHAEL S | See Remarks | Nov 14 '23 | Buy | 1.70 | 147,058 | 249,999 | 1,130,520 | Nov 16 05:46 PM |
|
|
| |
|
Market Cap | 8.54M | EPS (ttm) | -0.70 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | -32.55% |
P/S | 0.40 | EPS next 5Y | - |
P/B | 3.20 | EPS Q/Q | 191.98% |
Dividend | - | Sales Q/Q | -84.00% |
Insider Own | 12.15% | Inst Own | 71.01% |
Insider Trans | -4.30% | Inst Trans | -0.90% |
Short Float | 0.05% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 2.77M | 52W Range | 0.08 - 0.71 |
|
|
|
Trinity Place Holdings, Inc. engages in the ownership, investment, management, and development of real estate properties. It also controls a variety of intellectual property assets focused on the consumer sector. The company was founded by Sy Syms in 1959 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MFP PARTNERS LP | 10% Owner | May 17 '24 | Sale | 0.16 | 124,609 | 19,937 | 8,882,617 | May 20 04:55 PM | MFP PARTNERS LP | 10% Owner | May 16 '24 | Sale | 0.15 | 217,927 | 32,689 | 9,007,226 | May 20 04:55 PM | MFP PARTNERS LP | 10% Owner | May 15 '24 | Sale | 0.14 | 7,464 | 1,045 | 9,225,153 | May 20 04:55 PM |
|
|
|
|
Market Cap | 1.55B | EPS (ttm) | -0.43 |
P/E | - | EPS this Y | 35.87% |
Forward P/E | - | EPS next Y | 31.07% |
PEG | - | EPS past 5Y | - |
P/S | 7.44 | EPS next 5Y | 31.20% |
P/B | 1.44 | EPS Q/Q | 22.83% |
Dividend | - | Sales Q/Q | -52.98% |
Insider Own | 33.26% | Inst Own | 58.21% |
Insider Trans | -0.49% | Inst Trans | 4.32% |
Short Float | 20.81% | Earnings | May 09/a |
Analyst Recom | 3.71 | Target Price | 1.43 |
Avg Volume | 36.28M | 52W Range | 0.72 - 2.55 |
|
|
May-17-24 01:58PM
|
Hedge Fund and Insider Trading News: Paul Marshall, Ray Dalio, Boaz Weinstein, Bill Ackman, Stanley Druckenmiller, Eisler Capital, Archegos Capital Management, Ginkgo Bioworks Holdings Inc (DNA), Visa Inc (VISA), and More
(Insider Monkey) |
May-15-24 07:01AM
|
Ginkgo Bioworks to Participate in Two Conferences in May
(PR Newswire) |
May-14-24 06:00PM
|
Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
(PR Newswire) |
May-13-24 04:05PM
|
Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE
(PR Newswire) +10.49% |
May-10-24 07:30AM
|
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
(InvestorPlace) -17.29% |
May-09-24 05:45PM
|
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Lags Revenue Estimates
(Zacks) |
04:01PM
|
Ginkgo Bioworks Reports First Quarter 2024 Financial Results
(PR Newswire) |
May-08-24 01:46PM
|
3 Meme Stocks to Sell in May Before They Crash & Burn
(InvestorPlace) |
May-07-24 12:31PM
|
Want $10,000? Invest $1,000 in These 3 Penny Stocks Now
(InvestorPlace) -5.48% |
11:43AM
|
16 Best US Stocks To Invest In Under $10
(Insider Monkey) |
|
Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DEKKERS MARIJN E | Director | May 16 '24 | Sale | 0.83 | 265,000 | 220,030 | 5,515,364 | May 20 04:54 PM | Sankar Shyam | Director | May 15 '24 | Buy | 0.82 | 625,000 | 514,750 | 2,356,874 | May 16 05:08 PM | SLOAN HARRY | Director | May 14 '24 | Buy | 0.91 | 297,619 | 271,815 | 718,540 | May 14 05:16 PM | DEKKERS MARIJN E | Director | May 14 '24 | Sale | 0.93 | 1,727,056 | 1,606,162 | 281,217 | May 14 05:13 PM | Coen Steven P. | See remarks | May 02 '24 | Sale | 0.84 | 131,928 | 111,479 | 162,527 | May 06 04:53 PM |
|
|
| |
|
Market Cap | 2.79B | EPS (ttm) | 3.16 |
P/E | 32.32 | EPS this Y | 13.18% |
Forward P/E | 59.23 | EPS next Y | 38.35% |
PEG | 646.37 | EPS past 5Y | - |
P/S | 11.75 | EPS next 5Y | 0.05% |
P/B | 11.81 | EPS Q/Q | -20.12% |
Dividend | - | Sales Q/Q | 17.63% |
Insider Own | 5.28% | Inst Own | 92.72% |
Insider Trans | -55.68% | Inst Trans | -0.44% |
Short Float | 2.03% | Earnings | May 13/a |
Analyst Recom | 1.00 | Target Price | 103.60 |
Avg Volume | 174.73K | 52W Range | 63.08 - 102.87 |
|
|
May-20-24 04:56PM
|
Agilysys Insider Sold Shares Worth $5,924,887, According to a Recent SEC Filing
(MT Newswires) |
May-16-24 02:46PM
|
Agilysys Stock Moving Up The Leadership Ladder; Earns 81 RS Rating
(Investor's Business Daily) |
May-14-24 04:30PM
|
Agilysys to Participate in 19th Annual Needham Technology, Media & Consumer Conference
(Business Wire) +14.90% |
03:37PM
|
Agilysys (AGYS) Shares Skyrocket, What You Need To Know
(StockStory) |
01:01PM
|
Agilysys Inc (AGYS) (Q4 2024) Earnings Call Transcript Highlights: Strong Growth and Strategic ...
(GuruFocus.com) |
12:41PM
|
Agilysys Off to 'Fast Start' After Strong Fiscal Q4, Upbeat Subscription Revenue Outlook, Oppenheimer Says
(MT Newswires) |
08:45AM
|
Oppenheimer Adjusts Agilysys Price Target to $100 From $95, Maintains Outperform Rating
(MT Newswires) |
08:21AM
|
Agilysys, Inc. (NASDAQ:AGYS) Q4 2024 Earnings Call Transcript
(Insider Monkey) |
May-13-24 09:54PM
|
AGYS Stock Earnings: Agilysys Beats EPS, Beats Revenue for Q4 2024
(InvestorPlace) |
05:15PM
|
Agilysys (AGYS) Tops Q4 Earnings and Revenue Estimates
(Zacks) |
|
Agilysys, Inc. operates as a technology company. It offers innovative software for point-of-sale, payment gateway, reservation and table management, guest offers management, property management, inventory and procurement, analytics, document management, and mobile and wireless solutions and services to the hospitality industry. The firm also serves the gaming industry for both corporate and tribal, hotels resort and cruise, foodservice management, and the restaurant, university, and healthcare sectors. The company was founded in 1963 and is headquartered in Alpharetta, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Badger Kyle C | SVP, GC and Secretary | May 17 '24 | Sale | 99.05 | 50,860 | 5,037,693 | 116,083 | May 20 04:51 PM | Badger Kyle C | SVP, GC and Secretary | May 16 '24 | Option Exercise | 0.00 | 75,249 | 0 | 191,332 | May 20 04:51 PM | Badger Kyle C | SVP, GC and Secretary | May 16 '24 | Sale | 99.15 | 8,948 | 887,194 | 166,943 | May 20 04:51 PM | SRINIVASAN RAMESH | President & CEO | Mar 10 '24 | Option Exercise | 76.53 | 11,309 | 865,478 | 643,060 | Mar 11 06:57 PM | KEATING MELVIN L | Director | Mar 05 '24 | Buy | 75.95 | 100 | 7,596 | 44,039 | Mar 07 04:39 PM |
|
|
|
|
Market Cap | 330.43B | EPS (ttm) | 14.91 |
P/E | 22.37 | EPS this Y | 1.33% |
Forward P/E | 20.53 | EPS next Y | 6.08% |
PEG | 5.33 | EPS past 5Y | 9.21% |
P/S | 2.18 | EPS next 5Y | 4.20% |
P/B | 316.81 | EPS Q/Q | -5.06% |
Dividend | 2.67% | Sales Q/Q | -2.25% |
Insider Own | 0.23% | Inst Own | 72.86% |
Insider Trans | -7.30% | Inst Trans | 0.42% |
Short Float | 0.87% | Earnings | May 14/b |
Analyst Recom | 2.05 | Target Price | 384.11 |
Avg Volume | 3.54M | 52W Range | 274.26 - 396.87 |
|
|
|
The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and decor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and equipment rental. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978, and is headquartered at Atlanta, GA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Carey Matt | EVP, Customer Experience | May 16 '24 | Option Exercise | 169.29 | 50,239 | 8,505,177 | 89,333 | May 20 04:50 PM | Carey Matt | EVP, Customer Experience | May 16 '24 | Sale | 345.18 | 56,008 | 19,332,587 | 33,325 | May 20 04:50 PM | Siddiqui Fahim | EVP and CIO | May 16 '24 | Sale | 343.79 | 3,000 | 1,031,370 | 8,155 | May 17 04:16 PM | Padilla Hector A | EVP - US Sales and Operations | May 15 '24 | Option Exercise | 189.25 | 82 | 15,518 | 14,097 | May 17 04:13 PM | Padilla Hector A | EVP - US Sales and Operations | May 15 '24 | Sale | 349.01 | 82 | 28,619 | 14,015 | May 17 04:13 PM |
|
|
|
|
Market Cap | 3.84B | EPS (ttm) | -0.02 |
P/E | - | EPS this Y | 253.25% |
Forward P/E | 41.82 | EPS next Y | 153.69% |
PEG | - | EPS past 5Y | - |
P/S | 4.00 | EPS next 5Y | - |
P/B | 11.13 | EPS Q/Q | 199.79% |
Dividend | - | Sales Q/Q | 45.81% |
Insider Own | 32.29% | Inst Own | 47.18% |
Insider Trans | -4.18% | Inst Trans | 4.52% |
Short Float | 12.60% | Earnings | May 06/a |
Analyst Recom | 1.92 | Target Price | 16.56 |
Avg Volume | 7.72M | 52W Range | 5.65 - 20.11 |
|
|
|
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Becklund Irene | PAO | May 17 '24 | Option Exercise | 9.41 | 943 | 8,874 | 943 | May 20 04:43 PM | Becklund Irene | PAO | May 17 '24 | Sale | 14.50 | 943 | 13,674 | 0 | May 20 04:43 PM | Pendarvis Christiane | Director | May 13 '24 | Sale | 12.33 | 4,000 | 49,320 | 11,210 | May 14 04:18 PM | Boughton Soleil | Chief Legal Officer | May 13 '24 | Sale | 12.33 | 2,503 | 30,862 | 159,357 | May 14 04:17 PM | Carroll Patrick Harrison | Chief Medical Officer | May 09 '24 | Sale | 13.00 | 10,000 | 130,000 | 173,880 | May 13 04:21 PM |
|
|
|